Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09KRV
|
|||
| Former ID |
DIB016277
|
|||
| Drug Name |
Adhexil
|
|||
| Indication | Injury [ICD-11: NA00-ND5Z] | Phase 3 | [1] | |
| Company |
OMRIX Biopharmaceuticals SA
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fibrin (FG) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00865488) Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery. U.S. National Institutes of Health. | |||
| REF 2 | Evaluation of a fibrin preparation containing tranexamic acid (Adhexil) in a rabbit uterine horn model of adhesions with and without bleeding and in a model with two surgical loci. Fertil Steril. 2010 Mar 1;93(4):1045-51. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.